Clinical review

for general practice
  • Home
  • about
  • archives
  • contacts
left
FULLSCREEN > Archive > 2019 > №1 (2019) > Prostate cancer therapy: combination of androgen deprivation therapy with apalutamide. Clinical research results and real-world practice data

Prostate cancer therapy: combination of androgen deprivation therapy with apalutamide. Clinical research results and real-world practice data

Various authors

For citation:


  • Abstract

Abstract

In 2019, an important event for specialists of various profiles took place – the Congress of Oncologists of Russia (oncology-russia.ru ), which brought together more than 1,500 specialists in the field of oncology, radiology, radiation and instrumental diagnostics, palliative care and other related specialties. The participants raised the most pressing issues related to solving the problems of early diagnosis of all types of cancer, got acquainted with modern methods of treatment of malignant neoplasms, exchanged experience in managing patients.

Key words: prostate cancer, therapy, 2nd generation antiandrogens, apalutamide.


About the Author

Various authors

For citation:Prostate cancer therapy: combination of androgen deprivation therapy with apalutamide. Clinical research results and real-world practice data. Clinical review for general practice. 2019; 1: 33-36


All accepted articles publish licensed under a Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.

  • About
  • Editorial board
  • Ethics
  • For authors
  • Author fees
  • Peer review
  • Contacts

oa
crossref
анри


  Indexing

doaj
elibrary

Address of the Editorial Office:

127055, Moscow, s/m 37

Correspondence address:

115054, Moscow, Zhukov passage, 19, fl. 2, room XI


Managing Editor:

+7 (495) 926-29-83

id@con-med.ru